secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beta Bionics, Inc. (BBNX)
CIK:        0001674632
Form:       8-K
Filed at:   2026-09-16T22:24:10+00:00
Accession:  0001193125-26-393322
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beta Bionics prices $150M public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Priced 7,652,175 common shares at $17.25 and 1,043,484 pre-funded warrants at $17.2499 per share.
- Gross proceeds expected ~$150.0M; closing expected Sept 17, 2026.
- Underwriters granted 30-day option to purchase up to 1,304,348 additional shares.
- Proceeds for general corporate purposes including Mint commercialization, manufacturing expansion, R&D.
- J.P. Morgan, Piper Sandler, Wells Fargo, and Leerink act as joint book-running managers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674632/000119312526393322/0001193125-26-393322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674632/000119312526393322/d178069d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-393322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer